Cytoreason融资
WebSep 20, 2024 · Pharmaceutical giant Pfizer is making a $20 million investment in Israeli firm CytoReason, a developer of computational disease models for drug discovery and development, as part of a wider deal ... WebJul 30, 2024 · CytoReason was founded in 2016 by researchers and scientists from the Technion-Israel Institute of Technology. It was founded with the goal of leveraging new technology to address the increasing ...
Cytoreason融资
Did you know?
WebFeb 13, 2024 · CytoReason is a technology company developing a computational model of the human body that simulates human disease on a cellular level, minimizes the need for animal trials, and makes human … WebNov 16, 2024 · 根据协议条款，辉瑞将进行2000万美元的股权投资，拥有许可CytoReason平台和疾病模型的选择权，并资助补充项目，这笔交易在未来五年内的价值可能高达1.1亿 …
WebImmune-mediated Examples Inflammatory Bowel Disease, Atopic Dermatitis, Rheumatoid Arthritis, Asthma Immuno-oncology Examples Non-small Cell Lung Cancer, Renal Cell Carcinoma, Melanoma Fibrosis Examples Non-alcoholic steatohepatitis, Systemic Sclerosis, Idiopathic Pulmonary Fibrosis One universe linking mechanisms across diseases, … WebCytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by ...
WebApr 12, 2024 · CytoReason is a leading technology company developing computational disease models. The company collects proprietary data from pharmaceutical companies and uses it to simulate human diseases ... WebFeb 10, 2024 · CytoReason is a leading technology company developing computational disease models. The company collects proprietary data from pharmaceutical companies and uses it to simulate human diseases ...
WebCytoReason General Information Description Provider of cell-based models and data analysis services intended to develop a computational model of the human body that …
WebJul 18, 2024 · CytoReason创立于2016年，总部位于以色列特拉维夫，基于以色列理工学院和斯坦福大学的研究而来，团队由65名计算生物学家、临床医学家、数据科学家组成， … phone number for bugmdWebSep 21, 2024 · 根据合作协议， 辉瑞将对CytoReason进行2,000万美元的股权投资，并获得CytoReason专有的AI技术平台和疾病模型的使用授权加速新药研发。 此外， … how do you pronounce siddhartha gautamaWebSep 30, 2024 · CytoReason helps pharma and biotech companies accelerate drug discovery and development with the use of its cell-centered computational models and … how do you pronounce silversteinWebSep 21, 2024 · Pfizer and CytoReason have expanded their multi-year collaboration to leverage the latter’s artificial intelligence (AI) technology to discover and develop the former’s drug programmes.. According to the deal, Pfizer will invest $20m in equity, hold options for licencing the platform and disease models of CytoReason, and provide … phone number for bulovaWebSep 20, 2024 · Advanced insights from CytoReason’s disease models will support Pfizer’s drug development processTEL AVIV, Israel, Sept. 20, 2024 (GLOBE NEWSWIRE) -- CytoReason today announced an extension of ... phone number for buffalo wild wingsWeblicense CytoReason’s platform and disease models, and fund supplementary project support, in a deal potentially worth up to $110M over the next five years. Since launching … how do you pronounce simethiconeWebCytoReason is located in Tel Aviv, Tel Aviv, Israel. Who invested in CytoReason? CytoReason has 3 investors including Pfizer and … phone number for builders in hayes